
Finerenone Impurity 23 NEW
Price | Get Latest Price | ||
Package | 5mg | 20mg | 50mg |
Min. Order: | 1mg |
Supply Ability: | 100000 |
Update Time: | 2025-05-27 |
Product Details
Product Name: Finerenone Impurity 23 | CAS No.: 2084136-51-4 |
Min. Order: 1mg | Purity: >95% HPLC |
Supply Ability: 100000 | Release date: 2025/05/27 |
Molecular Formula:: C21H20N4O3 | Molecular Weight:: 376.41 |
Appearance: Pale yellow soild | Storage: 2-8°C Refrigerator |
Product Catalog: | F044023 |
CAS No.: | 2084136-51-4 |
Product Name: | Finerenone Impurity 23 |
Purity: | >95% HPLC |
Synonyms: | 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine-3-carboxamide |
Molecular Formula: | C21H20N4O3 |
Mol. Weight: | 376.41 |
Appearance: | Pale yellow soild |
Storage: | 2-8°C Refrigerator |
Contact: | WhatsAPP: +86 17320513646 E-mail: anna@molcoo.com |
Note: | We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS. This product is intended for laboratory use only! |
Background: | Finerenone Impurity 23 is an impurity related to finerenone, a medication used to treat chronic kidney disease and reduce the risk of cardiovascular events in patients with type 2 diabetes - associated kidney problems. Regulatory authorities require strict control and characterization of impurities to ensure the quality of pharmaceutical products. This involves detailed studies on their formation mechanisms, detection methods, and quantification. By understanding and managing Finerenone Impurities, pharmaceutical companies can enhance the quality and reliability of finerenone - based medications, thereby improving patient outcomes and safety. |
Company Profile Introduction
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/5mg |
VIP1Y
|
Guangzhou Tosun Pharmaceutical Ltd
|
2025-02-10 | |
$85.00/1kg |
VIP2Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2023-11-04 | |
$0.00/25kg |
VIP2Y
|
PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD
|
2024-05-13 |
INQUIRY